ConsensusCurrent
DGN — Guideline for the management of myasthenic syndromes
German Neurological Society expert guideline group, 2023
Myasthenic crisis requires rapid respiratory assessment and ICU support; IVIG, plasma exchange or immunoadsorption are established rapid immunomodulatory options, while longer-term disease control increasingly incorporates antibody status, disease activity and newer targeted immunotherapies.
Expert opinionLow certainty
View source guideline